PDCD1 and neoplasm: Notably, the enrichment was particularly pronounced in the PF, where nearly all patients (93%) displayed PD-1 expression on a distinct NK cell subset, suggesting active induction and/or preferential accumulation of PD-1+ NK cells within the tumor microenvironment (TME) (Fig. 1 a-b).